US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist
  • 1.700
  • -0.215-11.24%
Trading May 10 12:18 ET
82.68MMarket Cap-1588P/E (TTM)

Cue Biopharma Key Stats

Cue Biopharma Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

1.82M

+1105.96%
EPS(YoY)

-0.29

+23.68%

Strong Buy

Apr 30, 2024

Cue Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.277M--
--2024/Q2-- / 1.272M--
--2024/Q11.717M / 1.213M--
--2023/Q41.821M / 1.567M--
Nov 9, 20232023/Q32.100M / 1.120M--
Aug 9, 20232023/Q21.382M / 907.500K--
--2023/Q1187.000K / 1.950M--
Mar 21, 20232022/Q4151.230K / 103.750K--
Nov 14, 20222022/Q368.000K / 440.330K--
Aug 23, 20222022/Q226.000K / 1.131M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.277M--
--2024/Q2-- / 1.272M--
--2024/Q11.717M / 1.213M--
--2023/Q41.821M / 1.567M--
Nov 9, 20232023/Q32.100M / 1.120M--
Aug 9, 20232023/Q21.382M / 907.500K--
--2023/Q1187.000K / 1.950M--
Mar 21, 20232022/Q4151.230K / 103.750K--
Nov 14, 20222022/Q368.000K / 440.330K--
Aug 23, 20222022/Q226.000K / 1.131M--

Unlock Free Earnings Estimates

Cue Biopharma Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg